Calidi Biotherapeutics (CLDI) Q3 2025 Earnings

8AugConfirmed
Q3 2024
Q4 2024
Q2 2025
Q3 2025
-2.16
-1.66
-1.15
-0.65

Details

Expected EPS
-1.92
Actual EPS
-1.99
Surprise EPS
-0.07
Surprise Percent
+3.65%

Description

Calidi Biotherapeutics (CLDI) has reported earnings of -1.99 per share for Q3 2025.

0 Comments

Share your thoughts